Endometriosis Clinical Trial
Official title:
Flexofytol®, a Curcuma Extract, for the Treatment of Endometriosis- Associated Pain: a Randomized, Double Blind, Placebo-controlled Study
Endometriosis is a benign disease that affects 6-10% of women of reproductive age. The wide
range of symptoms observed in patients with endometriosis is due to implantation of
endometrial tissue outside the uterine cavity. This ectopic endometrium is subjected to
cyclic changes similar to that of eutopic endometrium. Typically, ectopic lesions are found
in the pelvis, notably on the ovaries in the form of cysts (endometriomas), as well as the
rectouterine and vesicouterine pouch. Lesions have also been described in other parts of the
abdomen and in other locations outside the abdominal cavity.
Although endometriosis has also been described in asymptomatic patients, possible symptoms
range from mild to severe pain presenting itself as dysmenorrhea, dyspareunia, or dyschezia,
or as infertility. Since the clinical picture varies, the treatment of this disease has
become quite personalized. Many studies conducted over the past several years have presented
different treatment options for the symptoms caused by endometriosis.
Turmeric, which is won from the rootstalks of Curcuma longa, has more than 300 biologically
active elements. One of the three main curcuminoids that are derived from turmeric, is
curcumin. Several in-vitro and animal studies have described anti-oxidant, anti-inflammatory
and anti-angiogenic effects of curcumin.
The main objective for the treatment of endometriosis patients is symptom relief. Treatment
options include analgesic therapies, hormonal therapies, laparoscopic surgery or a
combination of these. For patients who refuse hormonal therapies however, conservative
treatment options are limited.
Curcuma is a substance that has been in use for centuries, especially in ayurvedic and
Traditional Chinese Medicine for the treatment of various symptoms, notably for pain
alleviation in inflammatory illnesses. Several recently published studies have shown very
promising results of Flexofytol for pain alleviation in patients with osteoarthritis, due to
its anti-inflammatory and anti-oxidant properties. Due to these properties of curcuma, we aim
to analyse if curcuma capsules, sold by the pharmaceutical company Tilman under the name
Flexofytol®, can be used to alleviate symptoms in patients suffering from endometriosis.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01931670 -
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
|
Phase 3 | |
Recruiting |
NCT05648669 -
A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain
|
Phase 3 | |
Completed |
NCT04081532 -
The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain
|
N/A | |
Recruiting |
NCT06101303 -
Endometriosis Pain
|
||
Completed |
NCT04665414 -
Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
|
||
Completed |
NCT03690765 -
Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis
|
||
Recruiting |
NCT05153512 -
ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)
|
||
Active, not recruiting |
NCT04171297 -
Ultrasound Evaluation of the Pelvis in Women With Suspected Endometriosis Scheduled for Laparoscopic Surgery
|
||
Recruiting |
NCT04172272 -
The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures
|
N/A | |
Completed |
NCT04565470 -
Strategies of Self-management of Endometriosis Symptoms
|
||
Completed |
NCT03613298 -
Treatment by HIFU With Focal One® of Posterior Deep Infiltrating Endometriosis Lesions With Intestinal Involvement.
|
N/A | |
Withdrawn |
NCT05568940 -
Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
|
||
Not yet recruiting |
NCT03464799 -
Does Immunotherapy Have a Role in the Management of Endometriosis?
|
||
Active, not recruiting |
NCT03002870 -
Characteristics of Patient Population With Endometriosis
|
N/A | |
Completed |
NCT02973854 -
Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat
|
||
Withdrawn |
NCT03272360 -
Endometriosis Biomarker Discovery Study
|
N/A | |
Recruiting |
NCT02481739 -
Laparoscopic Surgical Management of Endometriosis on Fertility
|
N/A | |
Active, not recruiting |
NCT02754648 -
Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve
|
N/A | |
Completed |
NCT06106932 -
GnRH-a on Angiogenesis of Endometriosis
|
N/A | |
Completed |
NCT02387931 -
Supplementation in Adolescent Girls With Endometriosis
|
Phase 4 |